Mandate

Vinge advises EOS Russia

May 30, 2008

Vinge has been advising and representing EOS Russia in connection with the completion of the company’s series of share issues, directed to investors in Sweden and abroad. The offer was effectuated through “reoccurring demand driven pricing and settlement” and, following completion of the offer, the total proceeds of issue amounted to approximately SEK 2.1 billion. Participating banks in the transaction were Troika Dialog and Carnegie.

The Vinge team principally included Lena Almefelt, Rikard Stenberg, Petter Alberts, Henrik Fritz, Andreas Johard and Johan Thiman.

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025